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In mice infected with Riley virus (1), the activities of a number of plasma en- 
zymes are permanently elevated (2, 3). Similar, although temporary, increases 
in plasma enzyme activity  have been produced in mice by the administration of 
certain substances which reduce the phagocytic activity of the reticuloendo- 
thelial system (RES), and so it was suggested that in both cases the increased 
plasma enzyme levels might be caused by inhibition of plasma enzyme clear- 
ance by the RES (4).  Previous studies in Riley virus-infected mice have dem- 
onstrated a reduced rate of plasma clearance for those enzymes which have an 
increased activity in the plasma of infected mice. The enzymes for which this 
relationship  has  been  demonstrated are  lactate  dehydrogenase  (LDH),  iso- 
citrate  dehydrogenase,  malate  dehydrogenase,  and  aspartate  transaminase 
(formerly  called  glutamic-oxalacetic  transaminase)  (5-7).  With  two  other 
enzymes, alkaline phosphatase and the LDH-1  isoenzyme of LDH, the rate 
of clearance from the plasma was the same in normal and Riley virus-infected 
mice, and the plasma activities of these enzymes remain unchanged after Riley 
virus infection (6, 8). 
The present study was undertaken to extend previous work on plasma en- 
zyme clearance  in  Riley virus-infected mice,  and  to  examine the  effect of 
altered RES activity on plasma LDH clearance in noninfected mice. 
Materials and Metkods 
Animals.--Randomly bred albino male mice of the Parkes strain were used at 6-8 wk of age. 
Injections and Sampling.--Intravenous injections were made via the dorsal vein of the penis 
(9) and serial  blood samples  taken by tail bleeding  (10). The technique  of retro-orbital  bleeding 
was found to be unsatisfactory for enzyme clearance studies, as repeated hourly sampling 
caused local tissue damage and resulted in misleading  plasma enzyme  levels. 
Test Materials.---Crystalline  LDH from  rabbit muscle (C. F. Boehringer  and Soelme,  Mann- 
helm, Germany),  phosphoglucose  isomerase  from yeast (Boehringer  and Soehne),  and alanine 
transaminase (formerly  called glutamic-pyruvic  transaminase) from pig heart (Koch-Light 
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Laboratories Ltd., Colnbrook,  England) were centrifuged  out of suspension and the deposit 
dissolved in normal saline. The enzyme concentration was adjusted so that the required dose 
of enzyme could be given in a volume of 1 ml per 100 g body weight intravenously to each 
mouse. Colloidal carbon, stilbestrol, and cholesterol oleate were prepared for injection as pre- 
viously described (4). 
Daermino2ions.--Procedures for determining the activities of LDH, alanine transaminase, 
and phosphoglucose isomerase were  as previously described  (4).  All enzyme activities are 
expressed as international units (11). 
Riley Virus.--The virus preparation used in these experiments consisted of mouse plasma 
obtained from animals 24 hr after infection and diluted 1 in 100 in Hanks' saline containing 
0.5% gelatin (4). 
Enzyme Clearance.--The term clearance  refers  to the disappearance of enzyme activity 
from the peripheral circulation. Clearance rates were determined in individual mice by injec- 
ting purified enzyme intravenously and determining the plasma enzyme activity both prior to 
and at intervals up to 48 hr following injection. The initial plasma sample following injection 
was taken at 2 rain, when mixing was assumed to be complete in the peripheral circulation. 
The enzyme activity in the plasma prior to injection was taken as the steady-state activity 
(A oo) and the level 2 rain after injection as the activity at zero time (.4o). The clearance  of 
enzyme activity from the plasma was generally found to follow an exponential curve, and 
could be described by the equation: 
A  ffi  A0-e  -et  +  A o~ 
where A is the enzyme level at any time t, and C is the clearance coefficient. Plots of loge 
(A-Aoo) against t should thus give a straight line, the slope of which is the clearance coefficient. 
In all cases, the best straight line was calculated by the method of least squares.  However, 
in some experiments,  the clearance curve was found to have two phases, and in these cases 
the best straight line was calculated for each phase separately. 
RESULTS 
Clearance  of LDH  in  Normal  and Infected  Mice.--The  clearance  of LDH 
from  the plasma was  measured  after intravenous  injections of rabbit muscle 
LDH  (50,000 IU/100 g  body weight)  in both normal mice and mice infected 
several  days  previously  with  Riley  virus.  The  steady-state  level  (A o  o)  of 
plasma LDH  was  around  200  IU  per  liter in  normal  mice,  and  8-10  times 
higher in the infected mice. A  typical result is presented in Fig. 1. 
In normal mice, the LDH  clearance curve was biphasic and proceeded at a 
fast rate down to a level that varied between individual mice but was generally 
8(D-1,000  IU per  liter,  then  at  a  slower rate,  to  approach  the  steady-state 
level by 1-2 days. In Riley virus-infected mice, the initial fast clearance rate 
was either greatly reduced or did not appear at all (Fig. 1). The two clearance 
phases seen in normal mice must represent different processes. In the absence 
of more precise information as to their nature,  these two removal mechanisms 
will be referred to as the "fast" and "slow" phases. 
The fast clearance phase  in normal mice may be  the period during  which 
the injected enzyme is coming to an  equilibrium between  the plasma and an 
extravascular compartment,  such  as the interstitial fluid or cells of the RES. 
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been established. If this were so, it should be possible to block the fast dear- 
ance phase, or alter the plasma enzyme level at which the change in rate occurs, 
by repeated injections of LDH. Fig. 2 shows the results of such an attempt. 
Two  groups  of uninfected mice were  given intravenous injections of LDH, 
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I~G.  1.  Clearance of LDH from the plasma of an uninfected mouse, and a  mouse which 
had been infected with Riley virus 10 days previously. Each mouse was injected with 18,000 
IU/liter intravenously. 
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FIG. 2. Clearance of LDH from the plasma after intravenous injection of 3000 (•  •) 
or 7000 (O- --O)  IU/liter respectively into groups of normal mice. Each point represents a 
mean value obtained from four mice. Arrows show reinjection times. For further details see 
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l~c,. 3. Clearance  of LD[-[ from the plasma after intravenous injection of 1200 (O  O), 
2500  (O- -  -O), d000  (@- -  -O), or 10,000 (O  O) IU/liter respectively into groups of 
normal mice. Each point represents a mean value obtained from four mice. 
'.°  1 
ZO 
6.0" 
o 
Chotestero! ol~te 
HOUR5 
FIo. 4. Clearance of LDH from the plasma after injection of 1500 IU/liter intravenously 
into normal mice (e  e) and mice injected 24 hr previously with cholesterol oleate (O-- 
--O). Each point represents a mean value obtained from four mice. B.  W.  J.  MAHY,  K.  E.  K.  ROWSON,  AND  C.  W.  PARR  281 
each receiving a different dose. 2 hr later these doses were repeated, followed, 
in the case of the group receiving the lower LDH dose, by a third injection at 
4 hr. All the clearance curves had the slope of the fast phase; thus there was 
apparently  no  saturation  of  the  fast  phase  mechanism,  nor  was  there  any 
evidence that the change from fast to slow clearance phase was occurring at 
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FIG. 5. Clearance of LDH from the plasma after injection of 18,000 IU/liter intravenously 
into a  normal mouse (O  O), a  mouse injected 1 hr previously with 16 rag/100 g body 
weight of carbon intravenously (0- -  -0)  and a mouse infected for several weeks with Riley 
virus  (A  A)- 
an appreciably higher plasma enzyme level after the second or third enzyme 
injection than after the first. 
Another  possibility is  that  the  switch  from fast  to  slow  clearance phase 
involves some type of threshold mechanism,  so that  enzyme is  cleared at  a 
fast rate only down to a  critical plasma level. This hypothesis was supported 
by the following experiment. Groups of uninfected mice were given injections 
of LDH at various dose levels and the clearance studied for 6 hr (Fig. 3). The 
two  higher  doses  were  cleared  at  the  fast  rate  throughout  the  observation 
period, at the end of which the plasma level was still above 800 IU per liter, 
where the switch from fast to slow clearance had been shown to occur. How- 282  MECHANISM  OF  ACTION  OF  RILEY  VIRUS.  IV 
ever, at the lower dose levels, two clearance phases were seen, and the switch 
from fast to slow clearance again occurred at a plasma level of about 800 IU 
per liter. 
Relation  of RES  to  Plasma LDtt Clearance.--The  injection of mice  with 
RES-blocking agents causes an increase in the level of plasma LDH and certain 
other enzymes,  which  are  the same  enzymes as  are  affected by Riley virus 
infection  (4).  If  the  causative mechanism  is  the  same  in  both  cases,  RES- 
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FIo. 6. Clearance  of LDH from the plasma after injection of 21,000 IU/liter intravenously 
into  groups of normal mlce (O  0) and mice injected  2 days previously  with stilbestrol 
(O  'O). Each point  represents  a mean value  obtained  from three  mice. 
blocking agents should impair the fast LDH clearance phase in mice. To test 
this  hypothesis,  groups  of mice were injected intravenously with either  cho- 
lesterol oleate emulsion (100 mg/100 g body weight) or saline, and 24 hr later 
the  clearance rate of LDH was  measured following intravenous injection of 
enzyme (Fig. 4). The control mice showed the usual biphasic clearance curve, 
but in the cholesterol oleate-treated group, although the levels of plasma LDH 
were somewhat variable, only the slow clearance phase was seen. 
A similar experiment was carried out in which the function of the RES was 
blocked by an intravenous injection of carbon (16 mg/100 g  body weight)  1 
hr prior to studying LDH clearance. At this time, RES function as measured B.  W.  J.  MAHY,  K.  ~E.  K.  ROWSON~ AND  C.  W.  PARR  283 
by carbon clearance  was  somewhat  reduced,  though  not  so  greatly as  after 
cholesterol oleate (4). The rate of LDH clearance was compared in three mice, 
one normal, one treated with carbon, and one infected with Riley virus several 
weeks previously (Fig. 5). The dose of LDH chosen was high, so in the normal 
mouse only the fast clearance phase was observable over the period studied. 
Carbon injection reduced  the rate of LDH clearance but  not  to so great  an 
extent as Riley virus infection. 
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FIG. 7. Clearance of phosphoglucose  isomerase  from the plasma after intravenous injection 
of 8000 IU/liter into normal mice (O  •) and mice infected for several weeks with Riley 
vires (O  O). Each point represents a mean value obtained from four mice. 
Stimulation of the  RES  with  stilbestrol  lowers the  plasma LDH  level  in 
mice (4),  and it was therefore of interest to determine the effect of this sub- 
stance on LDH clearance. Mice were given a  single subcutaneous injection of 
0.1 mg stilbestrol in arachis oil, controls receiving arachis oil alone. This dose 
had been shown to cause marked stimulation of the RES 2 days later (4). The 
fast rate of LDH clearance, studied at this  time, was significantly greater in 
the stilbestrol-treated mice (Fig. 6). 
Clearance of Other Enzymes in Infected Mice.--The plasma enzyme increases 
observable in mice after blockade of the RES or Riley virus infection are of a 284  MECHANISM  OF ACTION OF RILEY VIRUS. IV 
specific pattern, some enzymes increasing in activity while others remain un- 
affected (12). On this basis it was suggested (4) that only those enzymes which 
are normally cleared by the RES are raised in Riley virus infection. It is dearly 
of considerable interest to know whether the clearance rates of enzymes other 
than LDH are altered during infection.  We therefore  studied in both normal 
and infected mice  the rates of clearance  of intravenously injected phospho- 
glucose isomerase and alanlne trausaminase.  The former enzyme activity is 
raised about tenfold in infected mice, while the activity of the latter enzyme 
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FIG. 8. Clearance of alanine transamina~ from the plasma after intravenous injection of 
800 IU/liter into normal mice (•.  •) and mice infected 7 days previously with Riley virus 
(O  O). Each point represents a mean value obtained from six mice. 
is unchanged (12). There was a  very marked impairment of phosphoglucose 
isomerase clearance in infected mice (Fig.  7),  but alanine transaminase clear- 
ance was unaltered (Fig.  8). No evidence of fast and slow clearance mecha- 
nisms was observed with either of these enzymes over the period studied. 
DISCUSSION 
It is clear that a basic difficulty associated with enzyme clearance studies is 
the lack of precise knowledge of the fate of injected enzymes. Many clearance 
studies have been carried  out using radioactively labeled proteins.  In some of 
these the rate of elimination of label from the whole body has been followed 
(13) while in others the labeled protein has been measured in the extravascular 
fluid  (14). Wasserman  and Mayerson (14) found that in dogs the disappear- B.  W.  J.  MAHY,  K.  E.  K.  ROWSON,  AND  (2.  W.  PARR  285 
ance of labeled albumin from the plasma followed a biphasic exponential curve. 
The fast phase was considered to represent  mixing with the interstitial fluid 
and lymph, and the slow phase to represent  metabolism of the albumin. Al- 
though some radioactivity was present in the urine and bile, this appeared to 
be  associated  with breakdown products  of  the originally injected material. 
Other workers have confirmed these results,  and also the biphasic  nature of 
the protein clearance curve with both albumin and globulin (15-18). 
Enzyme clearance studies trace an active group or region of a protein mole- 
cule and so the possibility  exists that the observed elimination of enzyme ac- 
tivity from the plasma may be due, in part at least,  to inactivation in the 
plasma rather than to movement out of it. However, in clearance experiments 
using radioactively labeled enzymes, it has been shown that the radioactivity 
and enzyme activity disappear from the plasma at the same rate (19, 20) sug- 
gesting that the injected enzyme is removed from the plasma and not merely 
inactivated. 
If it is assumed that enzymes are cleared from the plasma in a manner simi- 
lar to radioactively labeled proteins,  the fast clearance phase could be due to 
the injected enzyme leaving the blood during the establishment of an equi- 
librium between  the  enzyme concentration in  the  blood  and  extravascular 
fluid, while the slow clearance phase could be due to metabolism of the injected 
enzyme. 
If this mechanism were the basis for the biphasic clearance curve obtained 
with injected LDH, the plasma enzyme level at which the change from fast 
to slow clearance  rate occurs should vary with the injected dose of enzyme 
and  following repeated  enzyme injections. However,  in  the  experiments re- 
ported above, there was no evidence of this; in fact, the plasma enzyme level 
at which the change from fast to slow clearance rate occurred was remarkably 
constant. This suggests that there is in the normal mouse a threshold level for 
plasma LDH, above which some emergency rapid clearance mechanism comes 
into operation.  The altered dearance curve obtained in Riley virus-infected 
mice could result from inhibition of this fast clearance mechanism.  However, 
there is no reason why this action alone should cause abnormally high plasma 
enzyme levels in Riley virtu-infected mice which have not been injected with 
enzyme, unless there is also increased  endogenous enzyme production in the 
infected mice. 
The slope  of the enzyme clearance  curve in Riley virtu-infected mice  is 
closely similar to that of the slow phase in normal mice. Now if this slow clear- 
ance rate is due to metabolism of the injected protein as has been suggested, 
it would appear that Riley virus has no effect on the metabolism of injected 
enzymes. In support of this view, Notkins and his colleagues (21) have shown 
that the catabolism of radioactively labeled globulin occurs at the same rate 
in normal and infected mice. 
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virus,  and  very similar  changes  are  produced  by RES-blocking agents.  Our 
previous finding that the injection of RES-blocking agents into mice resulted 
in elevated plasma LDH levels was open to criticism that the observed effects 
might be due in part to a liberation of enzyme consequent upon tissue damage 
by the drugs used,  rather than  to an inhibition of plasma  enzyme clearance 
alone.  The  present  results  show  clearly that  treatment  with  RES-blocking 
agents inhibits the clearance of injected LDH and supports the idea that Riley 
virus could act in a similar way. Wakim and Fleisher (22) have reported that 
zymosan-induced blockade of the RES in dogs results in a similar impairment 
of LDH clearance.  In addition they reported an accelerated clearance of as- 
partate  transaminase  during  the  RES-stimulating  phase  of  zymosan  treat- 
ment. In the present study, an accelerated enzyme clearance was found during 
TABLE I 
The Clearance of Enzymes flora the Plasma of Normal and Riley  Virus-lnfec~.d Mice 
Enzyme 
LDH* 
LDH-I~ 
LDH-5~ 
Phosphoglucose  isomerase§ 
Alanine transaminase  § 
Source 
Rabbit muscle 
Pig heart 
Rabbit muscle 
Yeast 
Pig heart 
Half-llfe  in the plasma 
Normal  Virus-infected 
hr  hr 
1.3  6.1 
7.2  6.0 
2.0  5.1 
1.8  20.3 
10.0  10.0 
* From Mahy, 1964 (5). 
~t From Mahy and Rowson, 1965 (8). 
§ From present paper. 
stimulation  of the RES with stilbestrol, and it is of considerable interest that 
mice treated with estradiol are reported to clear guinea pig serum  L-aspara- 
ginase  at  an  accelerated rate  compared  to  untreated mice  (23).  There now 
seems little doubt that the RES plays an important role in the clearance of 
a  number of plasma  enzymes, but there are wide differences in the clearance 
rates between enzymes. For example, the half-life of yeast  L-asparaginase in 
mice was found to be less than 30 rain, compared to 19 hr for the same enzyme 
derived from guinea pig serum (23). Similarly, there were wide differences be- 
tween the half-lives of aspaxtate transaminase isoenzymes I and II in dogs (22) 
and between LDH isoenzymes I  and V in mice (8). This suggests  that some 
enzymes may be cleared from the plasma in a different way; i.e., not by the RES 
but by some slower mechanism. The idea that some enzymes such as alanine 
transaminase are not cleared by the RES is  compatible with the report (22) 
that zymosan did not consistently affect the level of alanine transaminase in 
dogs. The present finding (Table I) that the enzymes whose clearance was unaf- B.  W.  J.  MAHY,  K.  E.  K.  ROWSON~  AND  C.  W.  PARR  287 
fected  by  Riley virus  (alanine  transaminase  and  LDH-1  isoenzyme)  were 
cleared more slowly in  normal mice than the enzymes affected by the virus 
(LDH-5 isoenzyme and phosphoglucose isomerase) supports both the hypothe- 
sis that Riley virus acts by inhibiting the clearance of enzymes by the RES, and 
the idea that the enzymes which the virus does not affect may be cleared by 
some system other than the ILES. 
SUMMARY 
The  plasma  clearance  d  intravenously injected  rabbit  muscle LDI-I  was 
studied.  In normal mice the clearance followed a  biphasic exponential curve 
comprising  an  initial  fast  and  subsequent  slow  phase.  Riley virus-infected 
mice showed only the slow phase d  enzyme clearance. The change from fast 
to slow clearance rate in normal mice appeared to depend upon the level of 
plasma enzyme activity rather than on the amount of enzyme cleared. 
Treatment d  mice with RES-blocking agents (cholesterol oleate and carbon) 
inhibited the fast clearance phase, whereas an RES-stimulating agent (stilbes- 
trol) caused an accelerated rate of enzyme clearance. 
Riley virus infection was found to inhibit the clearance of phosphoglucose 
isomerase,  but  had  no effect on the  clearance of alanine  transaminase.  The 
activity of the former enzyme is raised in the plasma of infected mice, whereas 
the activity of the latter enzyme is unaltered. 
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